Antibodies to HIV integrase catalyze site-specific degradation of their antigen

International Immunology

Volumn 23, Issue 10, 2011, Pages 601-612

  Odintsova, Elena S ^a   Baranova, Svetlana V ^a   Dmitrenok, Pavel S ^b   Rasskazov, Valeriy A ^b   Calmels, Christina ^c   Parissi, Vincent ^c   Andreola, Marie Line ^c   Buneva, Valentina N ^a,d   Zakharova, Olga D ^a   Nevinsky, Georgy A ^a,d  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^b PACIFIC INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d NOVOSIBIRSK STATE UNIVERSITY   (Russian Federation)

Author keywords

Catalytic antibodies; HIV infected patients; Human blood antibodies; Hydrolysis of HIV integrase

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTEGRASE; OLIGOPEPTIDE;

ADULT; AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ARTICLE; CATALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME KINETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCUBATION TIME; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN HYDROLYSIS; THIN LAYER CHROMATOGRAPHY;

ADOLESCENT; ADULT; BIOCATALYSIS; FEMALE; HIV ANTIBODIES; HIV ANTIGENS; HIV INFECTIONS; HIV INTEGRASE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; SUBSTRATE SPECIFICITY; YOUNG ADULT;

EID: 80053449227     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxr065     Document Type: Article

References (42)

1. Matsiota-Bernard, P., Mahana, W., Avrameas, S. and Nauciel, C. 1993 Specific and natural antibody production during Salmonella typhimurium infection in genetically susceptible and resistant mice. Immunology 79:375.
2. Matsiota-Bernard, P., Hentati, B., Pie, S., Legakis, N., Nauciel, C. and Avrameas, S. 1996. Beneficial effect of Salmonella typhimurium infection and of immunoglobulins from S. typhimuriuminfected mice on the autoimmune disease of (NZB x NZW) F1 mice. Clin. Exp. Immunol. 104:228.
3. Hentati, B., Sato, M. N., Payelle, B., Avrameas, S. and Ternynck, T. 1994 Beneficial effect of polyclonal immunoglobulins from malaria-infected BALB/c mice on the lupus-like syndrome of (NZB x NZW)F1 mice. Eur. J. Immunol. 24:8.
4. Ternynck, P., Falanga, B., Unterkircher, C. et al. 1991. Induction of high levels of IgG autoantibodies in mice infected with Plasmodium chabaudi. Int. Immunol. 3:29.
5. Barzilai, O., Ram, V. and Shoenfeld, Y. 2007. Viral infection can induce the production of autoantibodies. Curr. Opin. Rheumatol. 19:636.
6. Fauci, A. S., Braunwald, E., Kasper, D. L. et al. 2008. Harrison's Principles of Internal Medicine, 17th edn. McGraw-Hill Professional, New York, NY.
7. Zandman-Goddard, G. and Shoenfeld, Y. 2002. HIV and autoimmunity. Autoimmmun. Rev 1:329.
8. Asante-Appiah, E. and Skalka, A. M. 1999. HIV-1 integrase: structural organization, conformational changes, and catalysis. Adv. Virus Res 52:351.
9. Keinan, E., ed. 2005. Catalytic Antibodies. Wiley-VCH Verlag GmbH and Co. KgaA, Weinheim, Germany.
10. Nevinsky, G. A. and Buneva, V. N. 2002. Human catalytic RNAand DNA-hydrolyzing antibodies. J. Immunol. Methods 269:235.
11. Nevinsky, G. A., Favorova, O. O. and Buneva, V. N. 2002. Natural catalytic antibodies-new characters in the protein repertoire. In Golemis, E., ed., Protein-protein interactions; a molecular cloning manual, p. 523. Cold Spring Harbor Lab. Press, New York, NY.
12. Nevinsky, G. A. and Buneva, V. N. 2003. Catalytic antibodies in healthy humans and patients with autoimmune and viral pathologies. J. Cell. Mol. Med. 7:265.
13. Nevinsky, G. A. and Buneva, V. N. 2004. Natural catalytic antibodies-abzymes. In Keinan, E., ed., p.503. VCH-Wiley press, Weinheim, Germany.
14. Nevinsky, G. A. and Buneva, V. N. 2010. Natural catalytic antibodies in norm, autoimmune, viral, and bacterial diseases. ScientificWorldJournal 10:1203.
15. Paul, S., Volle, D. J., Beach, C. M., Johnson, D. R., Powell, M. J. and Massey, R. J. 1989. Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science 244:1158.
16. Kalaga, R., Li, L., O'Dell, J. R. and Paul, S. 1995. Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis. J. Immunol. 155:2695.
17. Thiagarajan, P., Dannenbring, R., Matsuura, K., Tramontano, A., Gololobov, G. and Paul, S. 2000. Monoclonal antibody light chain with prothrombinase activity. Biochemistry 39:6459.
18. Lacroix-Desmazes, S., Moreau, A., Sooryanarayana, et al. 1999. Catalytic activity of antibodies against factor VIII in patients with hemophilia A. Nat. Med. 5:1044.
19. Polosukhina, D. I., Kanyshkova, T., Doronin, B. M. et al. 2004. Hydrolysis of myelin basic protein by polyclonal catalytic IgGs from the sera of patients with multiple sclerosis. J. Cell. Mol. Med. 8:359.
20. Polosukhina, D. I., Buneva, V. N., Doronin, B. M. et al. 2006. Metal-dependent hydrolysis of myelin basic protein by IgGs from the sera of patients with multiple sclerosis. Immunol. Lett. 103:75.
21. Polosukhina, D. I., Buneva, V. N., Doronin, B. M. et al. 2005. Hydrolysis of myelin basic protein by IgM and IgA antibodies from the sera of patients with multiple sclerosis. Med. Sci. Monit. 11:BR266.
22. Savel'ev, A. N., Eneyskaya, E. V., Shabalin, K. A., Filatov, M. V. and Neustroev, K. N. 1999. Antibodies with amylolytic activity. Prot. Pept. Lett. 6:179.
23. Paul, S. 1998. Mechanism and functional role of antibody catalysis. Appl. Biochem. Biotechnol. 75:13.
24. Kozyr, A. V., Kolesnikov, A. V., Aleksandrova, E. S. et al. 1998. Autoantibodies to nuclear antigens: correlation between cytotoxicity and DNA-hydrolyzing activity. Appl. Biochem. Biotechnol. 75:45.
25. Sinohara, H. and Matsuura, K. 2000. Does catalytic activity of Bence-Jones proteins contribute to the pathogenesis of multiple myeloma? Appl. Biochem. Biotechnol. 83:85.
26. Nevinsky, G. A., Breusov, A. A., Baranovskii, A. G. et al. 2001. Effect of different drugs on the level of DNA-hydrolyzing polyclonal IgG antibodies in sera of patients with Hashimoto's thyroiditis and nontoxic nodal goiter. Med. Sci. Monit. 7:201.
27. Li, L., Paul, S., Tyutyulkova, S., Kazatchkine, M. D. and Kaveri, S. 1995 Catalytic activity of anti-thyroglobulin antibodies. J. Immunol. 154:3328.
28. Lacroix-Desmazes, S., Bayry, J., Kaveri, S. V. et al. 2005. High levels of catalytic antibodies correlate with favorable outcome in sepsis. Proc. Natl Acad. Sci. USA 102:4109.
29. Nishi, Y. 2003. Enzyme/abzyme prodrug activation systems: potential use in clinical oncology. Curr. Pharm. Des. 9:2113.
30. Stockwin, L. H. and Holmes, S. 2003. Antibodies as therapeutic agents: vive la renaissance!. Expert Opin. Biol. Ther. 3:1133.
31. Hanson, C. V., Nishiyama, Y. and Paul, S. 2005. Catalytic antibodies and their applications. Curr. Opin. Biotechnol. 16:631.
32. De Prada, P., Winger, G. and Landry, D. W. 2000. Application of artificial enzymes to the problem of cocaine. Ann. N.Y. Acad. Sci. 909:159.
33. Planque, S., Nishiyama, Y., Taguchi, H., Salas, M., Hanson, C. and Paul, S. 2008. Catalytic antibodies to HIV: physiological role and potential clinical utility. Autoimmun. Rev. 7:473.
34. Odintsova, E. S., Kharitonova, M. A., Baranovskii, A. G., Siziakina, L. P., Buneva, V. N. and Nevinsky, G. A. 2006. Proteolytic activity of IgG antibodies from blood of acquired immunodeficiency syndrome patients. Biochemistry (Mosc.) 71:251.
35. Baranova, S. V., Buneva, V. N., Kharitonova, M. A. et al. 2009. HIV-1 integrase-hydrolyzing antibodies from sera of HIV-infected patients. Biochimie 91:1081.
36. Baranova, S. V., Buneva, V. N., Kharitonova, M. A. et al. 2010. HIV-1 integrase-hydrolyzing IgM antibodies from sera of HIV-infected patients. Int. Immunol. 22:671.
37. Caumont, A., Jamieson, G., de Soultrait, V. et al. 1999. High affinity interaction of HIV-1 integrase with specific and nonspecific singlestranded short oligonucleotides. FEBS Lett. 455:154.
38. Ponomarenko, N. A., Durova, O. M., Vorobiev, I. I. et al. 2006. Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. Proc. Natl Acad. Sci. USA 103:281.
39. Odintsova, E. S., Buneva, V. N. and Nevinsky, G. A. 2005. Caseinhydrolyzing activity of sIgA antibodies from human milk. J. Mol. Recognit. 18:413.
40. Yi, J., Arthur, J. W., Dunbrack, R. L. Jr. and Skalka, A. M. 2000. An inhibitory monoclonal antibody binds at the turn of the helix-turnhelix motif in the N-terminal domain of HIV-1 integrase. J. Biol. Chem. 275:38739.
41. Bizub-Bender, D., Kulkosky, J. and Skalka, A. M. 1994. Monoclonal antibodies against HIV type 1 integrase: clues to molecular structure. AIDS Res. Hum. Retroviruses 10:1105.
42. Nilsen, B. M., Haugan, I. R., Berg, K., Olsen, L., Brown, P. O. and Helland, D. E. 1996. Monoclonal antibodies against human immunodeficiency virus type 1 integrase: epitope mapping and differential effects on integrase activities in vitro. J. Virol 70:1580.